Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HealthLynked (HLYK) Depreciation & Amortization - Total (2016 - 2025)

Historic Depreciation & Amortization - Total for HealthLynked (HLYK) over the last 8 years, with Q3 2025 value amounting to $20155.0.

  • HealthLynked's Depreciation & Amortization - Total fell 2714.88% to $20155.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $103853.0, marking a year-over-year decrease of 1190.84%. This contributed to the annual value of $115102.0 for FY2024, which is 707.69% down from last year.
  • Latest data reveals that HealthLynked reported Depreciation & Amortization - Total of $20155.0 as of Q3 2025, which was down 2714.88% from $27238.0 recorded in Q2 2025.
  • In the past 5 years, HealthLynked's Depreciation & Amortization - Total registered a high of $31253.0 during Q2 2023, and its lowest value of $20155.0 during Q3 2025.
  • Its 5-year average for Depreciation & Amortization - Total is $28111.7, with a median of $28208.0 in 2022.
  • As far as peak fluctuations go, HealthLynked's Depreciation & Amortization - Total soared by 2430.21% in 2023, and later tumbled by 2714.88% in 2025.
  • Over the past 5 years, HealthLynked's Depreciation & Amortization - Total (Quarter) stood at $25291.0 in 2021, then increased by 11.53% to $28208.0 in 2022, then rose by 10.7% to $31226.0 in 2023, then decreased by 8.93% to $28436.0 in 2024, then dropped by 29.12% to $20155.0 in 2025.
  • Its Depreciation & Amortization - Total stands at $20155.0 for Q3 2025, versus $27238.0 for Q2 2025 and $28024.0 for Q1 2025.